This is a Validated Antibody Database (VAD) review about Xenopus la.. acta2.L, based on 18 published articles (read how Labome selects the articles), using acta2.L antibody in all methods. It is aimed to help Labome visitors find the most suited acta2.L antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
acta2.L synonym: ASMA; SMactin; a-sma; aat6; acta2; acta2.S; actsa; alpha-actin; mymy5; sm-actin; sma
Invitrogen
mouse monoclonal (1A4) |
| Invitrogen acta2.L antibody (Neomarkers, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 3c). Biochem Biophys Rep (2022) ncbi |
mouse monoclonal (1A4) |
| Invitrogen acta2.L antibody (Thermo Fisher, 1A4) was used in immunohistochemistry - frozen section on mouse samples (fig 5a, 5b, 5c). PLoS ONE (2022) ncbi |
mouse monoclonal (1A4) |
| Invitrogen acta2.L antibody (eBioscience, 1A4) was used in immunocytochemistry on human samples (fig 2b). BMC Cancer (2020) ncbi |
mouse monoclonal (1A4) |
| In order to investigate the tumor microenvironment in tertiary lymphoid organs of prostate cancer patients, Invitrogen acta2.L antibody (Thermo Fisher Scientific, 1A4) was used in immunohistochemistry on human samples (fig 11a). Front Immunol (2017) ncbi |
mouse monoclonal (1A4) |
| In order to test if exogenous transfer of unphosphorylated phosphatase and tensin homologue deleted from chromosome 10 leads to reduce transforming growth factor beta-induced extracellular matrix expression in both epithelial cells and fibroblasts, Invitrogen acta2.L antibody (Lab Vision, 1A4) was used in western blot on human samples (fig 3e). Wound Repair Regen (2017) ncbi |
mouse monoclonal (1A4) |
| In order to characterize alterations in fibroblast populations in the skin of patients with systemic sclerosis, Invitrogen acta2.L antibody (Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples (fig 3b). Am J Pathol (2016) ncbi |
mouse monoclonal (1A4) |
| In order to study human lacrimal epithelium and histatin-1 expression, Invitrogen acta2.L antibody (Thermo Scientific, MS-113-P0) was used in immunohistochemistry - paraffin section on human samples (fig 2). PLoS ONE (2016) ncbi |
mouse monoclonal (1A4) |
| In order to present two cases of primary sclerosing epithelioid fibrosarcoma of the kidney, Invitrogen acta2.L antibody (NeoMarkers, 1A4) was used in immunohistochemistry on human samples at 1:1000 (fig 6). Diagn Pathol (2015) ncbi |
mouse monoclonal (1A4) |
| In order to study the epithelial and stromal alterations in prostate following cypermethrin administration in adult albino rats, Invitrogen acta2.L antibody (Lab Vision Corporation, alpha-Actin) was used in immunohistochemistry - paraffin section on rat samples at 1:5000. Tissue Cell (2015) ncbi |
mouse monoclonal (1A4) |
| In order to identify and characterize vessels that encapsulated tumor clusters in hepatocellular carcinoma sections, Invitrogen acta2.L antibody (Life Technologies, 1A4) was used in immunohistochemistry - paraffin section on human samples at 1:300. Hepatology (2015) ncbi |
mouse monoclonal (1A4) |
| In order to investigate the role of cannabinoid receptor type 2 (CB2R) during skeletal muscle regeneration, Invitrogen acta2.L antibody (Lab Vision, MS-113) was used in immunohistochemistry - paraffin section on rat samples at 1:200. Histol Histopathol (2015) ncbi |
mouse monoclonal (1A4) | In order to examine the adverse effect of prostaglandin F-receptor antagonist AS604872 on brain vasculature, Invitrogen acta2.L antibody (Thermo Scientific, MS113) was used . J Pharmacol Sci (2014) ncbi | |
mouse monoclonal (1A4) |
| In order to identify tissue origin of the granular cell tumor using immunohistochemistry, Invitrogen acta2.L antibody (LabVision, 1A4) was used in immunohistochemistry on human samples at 1:600. Arch Dermatol Res (2015) ncbi |
mouse monoclonal (1A4) |
| In order to characterize PDGF-mediated skeletal muscle angiogenesis and the role of CD248 (Endosialin), Invitrogen acta2.L antibody (NeoMarkers, 1A4) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 1). PLoS ONE (2014) ncbi |
mouse monoclonal (1A4) |
| In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Invitrogen acta2.L antibody (Fisher/Thermo Scientific, 1A4) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi |
mouse monoclonal (1A4) |
| In order to study the induction of inflammation, metaplasia and displasia following transgenic expression of IFN-gamma in the murine stomach, Invitrogen acta2.L antibody (NeoMarkers, MS-113-P0) was used in immunohistochemistry on mouse samples . Am J Pathol (2012) ncbi |
mouse monoclonal (1A4) |
| In order to investigate the effect of PEGDA hydrogel on the production of extracellular matrix from vocal fold fibroblasts, Invitrogen acta2.L antibody (LabVision, 1A4) was used in immunohistochemistry on human samples and in immunohistochemistry on pigs |
mouse monoclonal (1A4) |
| In order to report that disruption of the mouse Par3 gene results in midgestational embryonic lethality with defective epicardial development, Invitrogen acta2.L antibody (Zymed, 1A4) was used in immunohistochemistry - paraffin section on mouse samples at 0.34 ug/ml. Development (2006) ncbi |
Articles Reviewed
- Fukuda M, Aoki T, Manabe T, Maekawa A, Shirakawa T, Kataoka H, et al. Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872. J Pharmacol Sci. 2014;126:230-42 pubmed
- Hirose T, Karasawa M, Sugitani Y, Fujisawa M, Akimoto K, Ohno S, et al. PAR3 is essential for cyst-mediated epicardial development by establishing apical cortical domains. Development. 2006;133:1389-98 pubmed
articles
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments